Trial Holdings Inc.

Equities

141A

JP3635490000

Discount Stores

Market Closed - Japan Exchange 02:00:00 2024-04-26 am EDT 5-day change 1st Jan Change
2,709 JPY 0.00% Intraday chart for Trial Holdings Inc. +10.30% 0.00%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
AIM WINNERS & LOSERS: Mosman farm-in approved; Zenova's contract win AN
AstraZeneca makes progress with Truqap and Enhertu cancer treatments AN
AstraZeneca's Breast Cancer Drug Improves Progression-free Survival in Late-stage Study MT
AstraZeneca's Truqap Plus Faslodex Breast Cancer Treatment Bags EU Approval Recommendation MT
Hipgnosis Songs Fund backs new Blackstone bid AN
European Medicines Agency Committee Backs Roche's Subcutaneous Injection for Multiple Sclerosis MT
DISA Subsidiary Starts Trial Deployment of Vision Screening Tech in Vietnam MT
Keymed Biosciences Allergy Drug Achieves Phase III Clinical Trial End Points MT
Germany's 'Reichsbuerger' coup suspects go on trial RE
Russian journalist placed in pre-trial detention in alleged extremism case RE
Trump trial tests his campaign strategy of embracing bad publicity RE
'I have invited Biden to debate': Trump RE
Lawyers for Russia's deputy defence minister appeal his pre-trial detention, TASS reports RE
Pecker says he killed story to benefit Trump campaign RE
EU Panel Backs Approval of Takeda’s Colorectal Cancer Drug MT
Biodexa Pharmaceuticals Gets Exclusive License for Phase 3 Ready Drug to Treat Familial Adenomatous Polyposis -- Shares Jump MT
Allogene Therapeutics Gets $15 Million Grant from California Institute for Regenerative Medicine for Cancer Drug Development MT
Bristol-Myers Squibb Says European Regulator Recommends Approval of Bladder Cancer Combination Therapy MT
Romanian court says internet personality Tate's human trafficking trial can start RE
Proteome Sciences Wins GBP500,000 Spectrometry Services Contract in US MT
Proteome wins GBP500,000 deal to supply mass spectrometry services AN
Former tabloid publisher to face more questions in Trump hush-money trial RE
AIM WINNERS & LOSERS: Proteome Sciences rises on GBP500,000 contract AN
Thoma Bravo snaps up Darktrace for USD5 billion AN
CR Double-Crane Pharmaceutical's Unit Gets Nod to Trial New Pain Medication MT
Chart Trial Holdings Inc.
More charts
Trial Holdings Inc is a Japan-based holding company mainly engaged in the distribution and retail business and retail artificial intelligence (AI) business through its subsidiaries. The Company operates through two business segments. The Distribution and Retail segment mainly operates discount stores under the Trial brand that mainly provide daily necessities, home appliances, apparel goods, hobby goods, among others. Store formats include mega center, supercenter (SuC), smart and small store. The Retail Artificial Intelligence (AI) segment mainly provides products and solutions to retailers and food and consumer goods manufacturers that help improve customers' shopping experiences, physical store operations, and the efficiency of advertising and sales promotion activities. The Company also engages in resort-related businesses such as inn facilities and golf course management, as well as construction and real estate management business.
Calendar
More about the company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
2,709 JPY
Average target price
3,200 JPY
Spread / Average Target
+18.12%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 141A Stock
  4. News Trial Holdings Inc.
  5. Merck & Co.’s Keytruda Combination Treatments for Lung Cancer Gets EU Commission Approval